http://www.tricida.com
Tricida, Inc. Company Intro
Tricida, Inc., is a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of non-absorbed therapies. Tricida’s lead investigational drug candidate, TRC101, represents a first-in-class approach to the treatment of metabolic acidosis, a common complication of chronic kidney disease (CKD) that can result in increased mortality, accelerated progression of kidney disease, progressive muscle breakdown and exacerbation of bone disease.
Industry
Healthcare
Tricida, Inc. Headquaters
7000 Shoreline Court
South San Francisco,94080
United States
Tricida, Inc. Share price
17 May 2023 13:58 GMT
$0
0.0 (0 %)
Tricida, Inc. Market cap
$
WMC RANKING
2024
Tricida, Inc. # 90
Drug Manufacturers—Specialty & GenericLatest Tricida, Inc. News
12 Feb 2024
Global Chronic Kidney Disease Market 2024 - By Industry Research, Future Growth, Latest Trends And Forecast To
Press release - The Business research company - Global Chronic Kidney Disease Market 2024 - By Industry Research, Future Growth, Latest Trends And Forecast...
12 Feb 2024
Global Chronic Kidney Disease Market 2024 - By Industry Research, Future Growth, Latest Trends And Forecast To
Press release - The Business research company - Global Chronic Kidney Disease Market 2024 - By Industry Research, Future Growth, Latest Trends And Forecast...
12 Feb 2024
Global Chronic Kidney Disease Market 2024 - By Industry Research, Future Growth, Latest Trends And Forecast To
Press release - The Business research company - Global Chronic Kidney Disease Market 2024 - By Industry Research, Future Growth, Latest Trends And Forecast...
WMC Market Score
WMC Market to Revenue Score
Tricida, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Tricida, Inc. | USD | $0 | $220,563 | $-244,039 | $ 0.00 | 90 |
| Teva Pharmaceutical Industries Limited | USD | $16,283,000 | $4,659,000 | $-3,982,000 | $91,050B | 1 |
| Bausch Health Companies Inc. | USD | $8,042,000 | $4,348,001 | $-1,018,000 | $21,900B | 2 |
| Zoetis Inc. | USD | $7,012,000 | $2,380,000 | $1,774,000 | $826,670B | 3 |
| Perrigo Company plc | USD | $4,990,000 | $1,357,500 | $-230,900 | $44,310B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Tricida, Inc. Social Followers vs Top 4 Industry Competitors
Tricida, Inc. Post vs Top 4 Industry Competitors
Tricida, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Tricida, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Tricida, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Tricida, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Teva Pharmaceutical Industries Limited | 100 | 3.55 | 2.31 | 55 | 0 | 0 | 20.74 |
| Bausch Health Companies Inc. | 49.39 | 1.02 | 47.07 | 91 | 0 | 0 | 47.76 |
| Zoetis Inc. | 43.06 | 100 | 100 | 92 | 0 | 0 | 100 |
| Perrigo Company plc | 30.65 | 4.61 | 3.01 | 100 | 0 | 0 | 36.89 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
